Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials

被引:16
|
作者
Scheuermann, Joshua S. [1 ]
Reddin, Janet S. [1 ]
Opanowski, Adam [2 ]
Kinahan, Paul E. [3 ]
Siegel, Barry A. [4 ,5 ]
Shankar, Lalitha K. [6 ]
Karp, Joel S. [1 ]
机构
[1] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[2] Amer Coll Radiol Imaging Network, Philadelphia, PA USA
[3] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
[4] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
[5] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[6] NCI, Canc Imaging Program, Rockville, MD USA
关键词
CQIE; PET qualification; quantitative imaging; STANDARDIZED UPTAKE VALUE; F-18-FDG PET/CT; MULTICENTER TRIALS; FDG-PET/CT; NETWORK; EXPERIENCE; BIOMARKER; VARIANCE; PROTOCOL; THERAPY;
D O I
10.2967/jnumed.116.186759
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The National Cancer Institute developed the Centers for Quantitative Imaging Excellence (CQIE) initiative in 2010 to prequalify imaging facilities at all of the National Cancer Institute-designated comprehensive and clinical cancer centers for oncology trials using advanced imaging techniques, including PET. Here we review the CQIE PET/CT scanner qualification process and results in detail. Methods: Over a period of approximately 5 y, sites were requested to submit a variety of phantoms, including uniform and American College of Radiology-approved phantoms, PET/CT images, and examples of clinical images. Submissions were divided into 3 distinct time periods: initial submission (T0) and 2 requalification submissions (T1 and T2). Images were analyzed using standardized procedures, and scanners received a pass or fail designation. Sites had the opportunity to submit new data for scanners that failed. Quantitative results were compared across scanners within a given time period and across time periods for a given scanner. Results: Data from 65 unique PET/CT scanners across 56 sites were submitted for CQIE T0 qualification; 64 scanners passed the qualification. Data from 44 (68%) of those 65 scanners were submitted for T2. From T0 to T2, the percentage of scanners passing the CQIE qualification on the first attempt rose from 38% for T1 to 67% for T2. The most common reasons for failure were SUV outside specifications, incomplete submission, and uniformity issues. Uniform phantom and American College of Radiology-approved phantom results between scanner manufacturers were similar. Conclusion: The results of the CQIE process showed that periodic requalification may decrease the frequency of deficient data submissions. The CQIE project also highlighted the concern within imaging facilities about the burden of maintaining different qualifications and accreditations. Finally, for quantitative imaging-based trials, further evaluation of the relationships between the level of the qualification (e.g., bias or precision) and the quality of the image data, accrual rates, and study power is needed.
引用
收藏
页码:1065 / 1071
页数:7
相关论文
共 50 条
  • [21] Payer-Negotiated Prices for Cancer Services Across National Cancer Institute-Designated Cancer Centers
    O'Connor, John
    Sankaran, Roshun
    Diaz, Adrian
    Nuliyalu, Ushapoorna
    Ibrahim, Andrew M.
    Nathan, Hari
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S133 - S134
  • [22] Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers
    McDaniels-Davidson, Corinne
    Feng, Christine H.
    Martinez, Maria Elena
    Canchola, Alison J.
    Gomez, Scarlett Lin
    Nodora, Jesse N.
    Patel, Sandip P.
    Mundt, Arno J.
    Mayadev, Jyoti S.
    CANCER, 2022, 128 (19) : 3479 - 3486
  • [23] Industry Payments to Physician Directors of National Cancer Institute-Designated Cancer Centers, 2015-2017
    Carr, David
    Welch, H. Gilbert
    JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1595 - 1597
  • [24] The Role of Maxillofacial Prosthetics for the Surgically Treated Patient at National Cancer Institute-Designated Comprehensive Cancer Centers
    Rosen, Evan B.
    Palin, Charles L.
    Huryn, Joseph M.
    Wong, Richard J.
    LARYNGOSCOPE, 2019, 129 (02): : 409 - 414
  • [25] Analysis of Price Transparency for Oncologic Surgery Among National Cancer Institute-Designated Cancer Centers in 2020
    Xiao, Roy
    Miller, Lauren E.
    Workman, Alan D.
    Bartholomew, Ryan A.
    Xu, Lucy J.
    Rathi, Vinay K.
    JAMA SURGERY, 2021, 156 (06) : 582 - 585
  • [26] Availability of Integrative Medicine Therapies at National Cancer Institute-Designated Comprehensive Cancer Centers and Community Hospitals
    Desai, Krupali
    Liou, Kevin
    Liang, Kacy
    Seluzicki, Christina
    Mao, Jun J.
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2021, 27 (11) : 1011 - 1013
  • [27] Clinician-to-clinician connectedness and access to gastric cancer surgery at National Cancer Institute-designated cancer centers
    Aminpour, Nathan
    Phan, Vy
    Wang, Haijun
    McDermott, James
    Valentin, Michelle
    Mishra, Ankit
    DeLia, Derek
    Noel, Marcus
    Al-Refaie, Waddah
    JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (09) : 1526 - 1532
  • [28] Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers A Systematic Review and Online Audit
    Day, Andrew T.
    Tang, Liyang
    Karam-Hage, Maher
    Fakhry, Carole
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 407 - 410
  • [29] Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy
    Agarwal, Ankit
    Dayal, Anupriya
    Kircher, Sheetal M.
    Chen, Ronald C.
    Royce, Trevor J.
    JAMA ONCOLOGY, 2020, 6 (03) : 409 - 412
  • [30] Higher Prices for Cancer Surgery at National Cancer Institute-Designated Cancer Centers-Are Payers Achieving Value for Their Dollars?
    Keating, Nancy L.
    JAMA NETWORK OPEN, 2021, 4 (08)